Petro Starokadomskyy

Petro Starokadomskyy is a Senior Scientist at Kyverna Therapeutics since December 2022 and has been with UT Southwestern Medical Center since March 2010, where contributions include the discovery of two new human autoinflammatory syndromes as a group leader in molecular biology of rare diseases. Prior experience encompasses roles as a postdoctoral researcher in molecular immunology, leading to over three publications, and in molecular biology and cell assays at the Weizmann Institute of Science, resulting in the development and patenting of a novel technology. Petro's early career involved significant research at the Institute of Molecular Biology and Genetics, securing a Ph.D. in Biotechnology, and at Phage Biotechnology Corp, conducting successful trials and innovations in drug delivery systems. Educational qualifications include multiple postgraduate degrees and a doctoral degree in Biotechnology, substantiating a strong foundation in biochemistry and molecular biology.